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TENOGENIC DIFFERENTIATION PROTOCOL IN XENOGENIC-FREE
MEDIA ENHANCES TENDON-RELATED MARKER EXPRESSION IN
ADIPOSE-DERIVED STEM CELLS
D. Stanco, G. Soldati, G. Ciardelli
Tendon injuries are common and current therapies often are unsuccessful. Cell-based
therapy using mesenchymal stem cells (MSCs) seems to be the most promising approach to
heal tendon. Moreover, providing safe and regulated cell therapy products to patients
requires adherence to good manufacturing practices (GMP). Adipose-derived stem cells
(n=4) were cultured in 6-well plates coated with type-I collagen in a chemically de ned
serum-free medium (SF) or a xenogenic-free human pooled platelet lysate medium (hPL). At
passage 4, ASCs were induced to tendon lineage for 14 days using 100ng/ml CTGF, 10ng/ml
TGFβ3, 50ng/ml BMP12 and 50µg/ml ascorbic acid in the SF (SF-TENO) or in the hPL (hPL-
TENO) medium. Cells cultured without any supplements are used as control. Morphological
appearance, cell viability and FACS were performed in undi erentiated cells to evaluate the
xenogenic-free culture conditions; the gene and protein expression were performed by RT-
PCR and immuno uorescence to evaluate to expression of stem cell- and tendon-related
markers upon cell di erentiation. SF-CTRL and hPL-CTRL showed similar viability and MSC's
surface proteins and expressed the stemness markers NANOG, OCT4 and Ki67. Moreover,
both SF-TENO and hPL-TENO expressed signi cant higher levels of SCX, COL1A1, COL3A1,
COMP, MMP3 and MMP13 genes already at 3d (p<0.05) respect to CTRLs. Scleraxis and
collagen were also detected in both SF-TENO and hPL-TENO at protein level in higher
amount than CTRLs. In conclusion, ASCs exposed to CTGF, BMP12, TGFb3 and AA in both
serum and xenogenic-free media possess similar tenogenic di erentiation ability moving
forward the GMP-compliant approaches for the clinical use of ASCs.
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